Signoretti S - Search Results

1

LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer.

Xie H, Valera VA, Merino MJ, Amato AM, Signoretti S, Linehan WM, Sukhatme VP, Seth P. Xie H, et al. Among authors: signoretti s. Mol Cancer Ther. 2009 Mar;8(3):626-35. doi: 10.1158/1535-7163.MCT-08-1049. Epub 2009 Mar 10. Mol Cancer Ther. 2009. PMID: 19276158 Free PMC article.

2

Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.

Hines-Peralta A, Sukhatme V, Regan M, Signoretti S, Liu ZJ, Goldberg SN. Hines-Peralta A, et al. Among authors: signoretti s. Radiology. 2006 Jul;240(1):82-9. doi: 10.1148/radiol.2401050788. Epub 2006 May 23. Radiology. 2006. PMID: 16720872

3

The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancer.

Cho D, Signoretti S, Regan M, Mier JW, Atkins MB. Cho D, et al. Among authors: signoretti s. Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):758s-763s. doi: 10.1158/1078-0432.CCR-06-1986. Clin Cancer Res. 2007. PMID: 17255306 Review.

4

Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice.

Hakimé A, Hines-Peralta A, Peddi H, Atkins MB, Sukhatme VP, Signoretti S, Regan M, Goldberg SN. Hakimé A, et al. Among authors: signoretti s. Radiology. 2007 Aug;244(2):464-70. doi: 10.1148/radiol.2442061005. Radiology. 2007. PMID: 17641366

5

Tissue-based research in kidney cancer: current challenges and future directions.

Signoretti S, Bratslavsky G, Waldman FM, Reuter VE, Haaga J, Merino M, Thomas GV, Pins MR, Libermann T, Gillespie J, Tomaszewski JE, Compton CC, Hruszkewycz A, Linehan WM, Atkins MB. Signoretti S, et al. Clin Cancer Res. 2008 Jun 15;14(12):3699-705. doi: 10.1158/1078-0432.CCR-07-4733. Clin Cancer Res. 2008. PMID: 18559586 Free PMC article. Review.

6

Tissue biomarkers in renal cell carcinoma: issues and solutions.

Di Napoli A, Signoretti S. Di Napoli A, et al. Among authors: signoretti s. Cancer. 2009 May 15;115(10 Suppl):2290-7. doi: 10.1002/cncr.24233. Cancer. 2009. PMID: 19402057 Free PMC article. Review.

7

Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference.

Atkins MB, Bukowski RM, Escudier BJ, Figlin RA, Hudes GH, Kaelin WG Jr, Linehan WM, McDermott DF, Mier JW, Pedrosa I, Rini BI, Signoretti S, Sosman JA, Teh BT, Wood CG, Zurita AJ, King L. Atkins MB, et al. Among authors: signoretti s. Cancer. 2009 May 15;115(10 Suppl):2247-51. doi: 10.1002/cncr.24229. Cancer. 2009. PMID: 19402064 Free PMC article.

8

Treatment selection for patients with metastatic renal cell carcinoma.

Atkins MB, Choueiri TK, Cho D, Regan M, Signoretti S. Atkins MB, et al. Among authors: signoretti s. Cancer. 2009 May 15;115(10 Suppl):2327-33. doi: 10.1002/cncr.24231. Cancer. 2009. PMID: 19402069 Free PMC article. Review.

9

Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.

Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA, Sellers WR, Meyerson M, Linehan WM, Kaelin WG Jr, Signoretti S. Beroukhim R, et al. Among authors: signoretti s. Cancer Res. 2009 Jun 1;69(11):4674-81. doi: 10.1158/0008-5472.CAN-09-0146. Cancer Res. 2009. PMID: 19470766 Free PMC article.

10

p63 promotes cell survival through fatty acid synthase.

Sabbisetti V, Di Napoli A, Seeley A, Amato AM, O'Regan E, Ghebremichael M, Loda M, Signoretti S. Sabbisetti V, et al. Among authors: signoretti s. PLoS One. 2009 Jun 11;4(6):e5877. doi: 10.1371/journal.pone.0005877. PLoS One. 2009. PMID: 19517019 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

383 results

Search Page